BNP Paribas Discount Zert ABT 30..../ DE000PZ0UMZ1 /
2024-05-09 9:40:17 PM | Chg.-0.190 | Bid9:47:01 PM | Ask9:47:01 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
83.410EUR | -0.23% | 83.410 Bid Size: 1,700 |
83.460 Ask Size: 1,700 |
Abbott Laboratories | - USD | 2024-12-30 | Call |
GlobeNewswire
6:00 PM
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
03-25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
03-15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
2023-11-14
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
2023-10-19
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
2023-10-10
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
2023-10-02
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
GlobeNewswire
2023-09-06
Endexx Corporation Appoints Ahmed Itani to Director of Marketing of HYLA in The Middle East Region